Holdings of iShares U.S. Pharmaceuticals ETF
ISIN US4642888360
iShares Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 1.1B $ including 1.1B $ in equities, 99.9 %
- Positions
- 56 in 3 countries
- Top ten
- 76.1 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 1,005,964 | 255.5M $ | 22.44 % |
| 2 | Eli Lilly & Co | 211,122 | 253.2M $ | 22.25 % |
| 3 | Merck & Co Inc | 402,911 | 51.8M $ | 4.55 % |
| 4 | Bristol-Myers Squibb Co | 862,993 | 49.7M $ | 4.37 % |
| 5 | ROYALTY PHARMA PLC | 880,087 | 49.3M $ | 4.34 % |
| 6 | VIATRIS INC | 3,025,794 | 48M $ | 4.22 % |
| 7 | Pfizer Inc | 1,874,313 | 45.1M $ | 3.96 % |
| 8 | Zoetis Inc | 590,261 | 42.4M $ | 3.73 % |
| 9 | JAZZ PHARMACEUTICALS PLC | 163,023 | 39.3M $ | 3.45 % |
| 10 | ELANCO ANIMAL HEALTH INC | 1,297,692 | 31.9M $ | 2.81 % |
| 11 | Axsome Therapeutics Inc | 112,311 | 27.5M $ | 2.42 % |
| 12 | Corcept Therapeutics Inc | 248,243 | 21.6M $ | 1.90 % |
| 13 | Ligand Pharmaceuticals Inc | 52,070 | 16.5M $ | 1.45 % |
| 14 | Definium Therapeutics Inc | 336,035 | 15.8M $ | 1.39 % |
| 15 | Liquidia Corp | 182,536 | 14.6M $ | 1.28 % |
| 16 | Indivior Pharmaceuticals Inc | 316,782 | 13M $ | 1.14 % |
| 17 | Crinetics Pharmaceuticals Inc | 273,936 | 10.3M $ | 0.90 % |
| 18 | Organon & Co | 683,028 | 9.2M $ | 0.81 % |
| 19 | Edgewise Therapeutics Inc | 195,894 | 8M $ | 0.70 % |
| 20 | Amneal Pharmaceuticals Inc | 448,079 | 7.8M $ | 0.68 % |
| 21 | Enliven Therapeutics Inc | 141,435 | 7.2M $ | 0.63 % |
| 22 | Supernus Pharmaceuticals Inc | 150,961 | 7M $ | 0.62 % |
| 23 | TARSUS PHARMACEUTICALS INC | 102,786 | 6.5M $ | 0.57 % |
| 24 | VERADERMICS INC | 52,065 | 6.4M $ | 0.56 % |
| 25 | ALUMIS INC | 221,521 | 6.2M $ | 0.55 % |
| 26 | Nektar Therapeutics | 87,878 | 6.1M $ | 0.54 % |
| 27 | Prestige Consumer Healthcare Inc | 122,984 | 5.8M $ | 0.51 % |
| 28 | Trevi Therapeutics Inc | 306,511 | 5.7M $ | 0.50 % |
| 29 | OCULAR THERAPEUTIX INC | 455,448 | 4.5M $ | 0.39 % |
| 30 | Innoviva Inc | 182,305 | 4.1M $ | 0.36 % |
| 31 | AMYLYX PHARMACEUTICALS INC | 219,612 | 3.9M $ | 0.35 % |
| 32 | ANI Pharmaceuticals Inc | 47,404 | 3.9M $ | 0.34 % |
| 33 | MBX BIOSCIENCES INC | 69,247 | 3.8M $ | 0.34 % |
| 34 | Harmony Biosciences Holdings Inc | 103,804 | 3.8M $ | 0.33 % |
| 35 | Perrigo Co PLC | 359,528 | 3.7M $ | 0.33 % |
| 36 | Harrow Inc | 86,214 | 3.7M $ | 0.32 % |
| 37 | Nuvation Bio Inc | 633,601 | 3.6M $ | 0.32 % |
| 38 | Xeris Biopharma Holdings Inc | 448,501 | 3.6M $ | 0.31 % |
| 39 | Rapport Therapeutics Inc | 74,520 | 3.1M $ | 0.27 % |
| 40 | Collegium Pharmaceutical Inc | 84,237 | 3M $ | 0.27 % |
| 41 | EyePoint Inc | 204,659 | 2.9M $ | 0.26 % |
| 42 | AtaiBeckley Inc | 506,160 | 2.7M $ | 0.23 % |
| 43 | Pacira BioSciences Inc | 102,108 | 2.6M $ | 0.23 % |
| 44 | WAVE LIFE SCIENCES LTD | 394,231 | 2.3M $ | 0.20 % |
| 45 | Maze Therapeutics Inc | 73,160 | 2.2M $ | 0.19 % |
| 46 | LB Pharmaceuticals Inc | 63,173 | 2.1M $ | 0.18 % |
| 47 | BioAge Labs Inc | 82,938 | 2M $ | 0.18 % |
| 48 | Septerna Inc | 59,605 | 2M $ | 0.18 % |
| 49 | Amphastar Pharmaceuticals Inc | 88,493 | 1.8M $ | 0.16 % |
| 50 | OMEROS CORP | 187,604 | 1.8M $ | 0.16 % |
| 51 | Phibro Animal Health Corp | 54,917 | 1.7M $ | 0.15 % |
| 52 | Theravance Biopharma Inc | 98,073 | 1.7M $ | 0.15 % |
| 53 | CorMedix Inc | 190,159 | 1.5M $ | 0.13 % |
| 54 | Phathom Pharmaceuticals Inc | 133,024 | 1.4M $ | 0.13 % |
| 55 | Arvinas Inc | 168,155 | 1.4M $ | 0.12 % |
| 56 | Evolus Inc | 171,630 | 1.2M $ | 0.10 % |
Sector breakdown
- Health care 68.4 %
- Unattributed 31.6 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 96.0 %
- Ireland 3.8 %
- Singapore 0.2 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 53 | 1.1B $ | 96.02 % |
| 2 | Ireland | 2 | 43M $ | 3.78 % |
| 3 | Singapore | 1 | 2.3M $ | 0.20 % |
Cite this page
Titelia. "Holdings of iShares U.S. Pharmaceuticals ETF". https://titelia.com/en/funds/S000009417